OncoImmunology
Volume 10, 2021 - Issue 1
Open access
3,219
Views
26
CrossRef citations to date
0
Altmetric
Original Research
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis
Maen Abdelrahima Institute of Academic Medicine and Weill Cornell Medical College, Houston Methodist Cancer Center, Houston, Texas, USAView further author information
, Omar Mamloukb Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
, Heather Linc Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
, Jamie Linb Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
, Valda Pageb Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
, Noha Abdel-Wahabd Rheumatology and Rehabilitation Department, Assiut University Hospitals, Faculty of Medicine, Assiut, Egypt;e Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;f Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
, Joshua Swang Department of System Pharmacy, Houston Methodist, Houston, Texas, USAView further author information
, Umut Selameth Division of Renal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USAView further author information
, Cassian Yeef Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
, Adi Diabf Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAView further author information
, Wadi Sukii Department of Medicine, Nephrology, Houston Methodist Hospital, Houston, Texas, USAView further author information
& Ala Abudayyehb Section of Nephrology, Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USACorrespondence[email protected]
View further author information
show allView further author information
Article: 1927313
|
Received 19 Feb 2021, Accepted 04 May 2021, Published online: 23 May 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.